Is CMMB or CNSP more undervalued in 2026?

CirclFi compares Chemomab Therapeutics Ltd. (CMMB) and CNS Pharmaceuticals, Inc. (CNSP) using 13 institutional-grade valuation models. CMMB has a Quality of Company score of 1.9/10 while CNSP scores 3.6/10.

Which is a better buy — CMMB or CNSP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CMMB and CNSP valuations compare?

CMMB at $2.07 and CNSP at $4.89 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CMMB vs CNSP Valuation Comparison 2026 — Intrinsic Value Analysis

CMMB

Biotechnology

Chemomab Therapeutics Ltd.

Quality

1.9

out of 10

Value Trap

SAFE

Price

$2.07

Last close

Models

8/13

Active

CNSP

Biotechnology

CNS Pharmaceuticals, Inc.

Quality

3.6

out of 10

Value Trap

LOW

Price

$4.89

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	CMMB Fair Value	CMMB Upside	CNSP Fair Value	CNSP Upside
Bayesian DCF	Intrinsic	$0.55	-73.5%	$2.41	-50.6%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.26	-39.4%	$1.10	-52.2%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$0.07	-96.7%	—	—
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CMMB vs CNSP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CMMB vs CNSP — Which Stock Is More Undervalued?

CNSP scores higher with a 3.6/10 quality rating vs CMMB's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Chemomab Therapeutics Ltd. (CMMB) and CNS Pharmaceuticals, Inc. (CNSP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CMMB currently trades at $2.07 with a QOC of 1.9/10, while CNSP trades at $4.89 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).